Alaunos Therapeutics, Inc.
TCRT
$2.63
-$0.05-1.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.68M | -11.78M | -19.13M | -26.77M | -35.14M |
| Total Depreciation and Amortization | 2.00K | 244.00K | 923.00K | 1.62M | 2.32M |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 867.00K | 1.34M |
| Total Other Non-Cash Items | 435.00K | 3.29M | 5.34M | 6.75M | 7.60M |
| Change in Net Operating Assets | -729.00K | -3.52M | -4.49M | -5.14M | -6.25M |
| Cash from Operations | -4.97M | -11.76M | -17.36M | -22.68M | -30.14M |
| Capital Expenditure | -- | 0.00 | -1.00K | -136.00K | -197.00K |
| Sale of Property, Plant, and Equipment | -- | 1.50M | 1.51M | 1.51M | 1.54M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 1.50M | 1.50M | 1.37M | 1.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -125.00K | -125.00K | -11.98M | -18.23M |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 92.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 125.00K | 125.00K | 0.00 | 0.00 |
| Cash from Financing | -- | 0.00 | 0.00 | -11.98M | -18.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.97M | -10.26M | -15.85M | -33.29M | -46.93M |